Login / Signup

A phase 1b dose-escalation/expansion study of BET inhibitor RO6870810 in patients with advanced multiple myeloma.

Karthik RamasamyAjay K NookaHang QuachMyo HtutRakesh PopatMichaela LiedtkeSascha A TuchmanJacob P LaubachCristina GasparettoAsher Chanan-KhanMark HertzbergMark deMarioEveline NueeschEvelyne ChesneIzolda FranjkovicKatharina LechnerMartin KornackerHearn Jay Cho
Published in: Blood cancer journal (2021)
Keyphrases
  • multiple myeloma